Ensysce Biosciences Enrolls First Patient in Final Phase of PF614-MPAR-102 Clinical Study

June 26, 2026 8:00 AM

Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company pioneering next-generation pain and central nervous system therapeutics engineered to minimize abuse and overdose risk, today announced initiation of the final stage of the PF614-MPAR-102 clinical study. The study is evaluating its novel MPAR® (Multi-Pill Abuse Resistance) overdose-protection technology.Rather than relying on traditional...

Read more

Dr. Jason M. Cuéllar Performs Inaugural Surgery at DISC Surgery Center at Palm Beach

June 26, 2026 8:00 AM

Jason M. Cuéllar, M.D., Ph.D., performed the inaugural surgical procedure at the newly opened DISC Surgery Center at Palm Beach on Thursday, June 25, marking a significant milestone for both DISC Surgery Center at Palm Beach and Cuéllar Spine. The opening expands the practice's surgical capabilities while advancing Dr. Cuéllar's vision of delivering state-of-the-art, motion-preserving and minimally invasive spine care in a specialized outpatient...

Read more

Modular Medical Announces Shipment of Pivot Tubeless Patch Pumps

June 26, 2026 7:58 AM

Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a leader in innovative, patient-centric insulin delivery technology, today announced that the Pivot™ tubeless insulin patch pump is now shipping to physician offices for training. Upon completion of training, these pumps will be presented to potential patients in the next few days and weeks. The Company intends to expand the roster of practices that offer Pivot over the...

Read more

Cantargia Announces Publication of Data Supporting IL1RAP as a Therapeutic Target and Predictive Biomarker in PDAC

June 26, 2026 1:45 AM

Cantargia AB (publ) (STO:CANTA) today announced the publication of preclinical and clinical findings from the nadunolimab trial CANFOUR in the scientific journal JCI Insight. The results underscore the role of IL1RAP in pancreatic ductal adenocarcinoma (PDAC), its involvement in treatment resistance, and its potential as both a therapeutic target and predictive biomarker. The findings further support the potential of nadunolimab as a component...

Read more

Dr. John Spencer Ellis Expands Specialized Healthcare and Mental Health Marketing Services to Help Providers Thrive in the AI-Driven Search Era

June 26, 2026 1:15 AM

Dr. John Spencer Ellis, a healthcare industry veteran with over three decades of experience helping health and wellness professionals build successful practices, today announced the expansion of specialized marketing services designed specifically for healthcare providers and mental health professionals seeking to attract patients in an increasingly AI-dominated digital landscape. Through Reputation Return, his digital visibility and reputation...

Read more

CV Sciences Expands +PlusHLTH(TM) Portfolio with Personalized Wellness Solutions for Healthy Aging

June 25, 2026 8:00 PM

CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a consumer wellness company specializing in science-backed natural ingredients and products, today announced the expansion of its +PlusHLTH™ supplement portfolio with additional formulations supporting cellular integrity, metabolism, cognitive health, cardiovascular wellness, and movement. Health Intelligence is CV Sciences' approach to personalized wellness,...

Read more

ATC 2026 Concludes with Strong Attendance, Breakthrough Science, and Global Impact

June 25, 2026 4:00 PM

The American Transplant Congress (ATC) 2026, the joint annual meeting of the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS), concluded June 24 in Boston, bringing together 4,100+ attendees from 53 countries for five days of scientific exchange.Breakthrough Science on DisplayATC 2026 featured 220+ scientific sessions, including hot topic debates, interactive symposia and meet-the-expert sessions,...

Read more

How to Choose the Right Virtual Health System Solution for a Critical Access Hospital

June 25, 2026 4:00 PM

Rural hospitals are facing a level of pressure few healthcare organizations have experienced before.Patients are becoming more complex. Workforce shortages continue to grow. Tertiary care centers are overwhelmed. And critical access hospitals are increasingly being asked to care for sicker patients with fewer resources.According to Dr. Kelly Rhone, Chief Medical Officer and Board-Certified Emergency Physician at Avel eCare, rural healthcare...

Read more

Keila Hoover, MD, Joins MiAngel as Co-Founder and Chief Medical Officer

June 25, 2026 3:45 PM

MiAngel, Inc., the healthcare middleware company building the Trust Layer for AI, today announced that Keila Hoover, MD, has joined as Co-Founder, Chief Medical Officer, and Board Director.Hoover brings 23 years of clinical practice and healthcare entrepreneurship. She is the CEO of Premium Healthcare, a six-location, multi-specialty network serving Miami-Dade County across primary care, pediatrics, urgent care, senior care, imaging, and...

Read more

State Marijuana Products Can Not Enter Schedule III Without Demonstrating the Chemical Consistency Required by Federal Regulation

June 25, 2026 12:35 PM

If Schedule III Requires "Defined Chemical Composition," Which State Marijuana Operators Actually Meet the DOJ's Own 2020 Standard?As the Drug Enforcement Administration prepares for its June 29 administrative hearing on marijuana rescheduling, MMJ International Holdings, Inc. (MMJIH) is calling attention to a critical federal requirement that has received virtually no public discussion: the Department of Justice's own 2020 Final Rule governing...

Read more

Duly Becomes First Ambulatory Surgery Center in Illinois to Offer Da Vinci 5 Surgical Robot

June 25, 2026 11:45 AM

Duly Health and Care unveiled the new Da Vinci 5 (DV 5) surgical robot at its Lombard Surgery Center today, making it the first ambulatory surgery center in Illinois -- and among only five nationally -- to offer the latest generation of robotic-assisted surgical technology."Some of the best surgical outcomes are the complications patients never experience, made possible by the precision and control that robotic technology brings to modern...

Read more

Cercare Medical Receives FDA 510(k) Clearance for AI-Powered Brain Tumor Segmentation

June 25, 2026 11:00 AM

Cercare Medical, a leader in advanced neuroimaging software, today announced FDA 510(k) clearance (K260316) for its Oncology Virtual Expert, an AI-powered brain tumor segmentation module designed to deliver fast, consistent, and semi-automated tumor analysis directly within existing clinical radiology workflows.The clearance marks a significant milestone in Cercare Medical's strategy to expand into the North American market, bringing advanced...

Read more

Medical Care Technologies, Inc. (OTC Pink:MDCE) Showcases Diversified Technology Portfolio with Newly Launched Platforms Across AI Health, Enterprise Vision Solutions, and Collectibles Markets

June 25, 2026 9:17 AM

Medical Care Technologies, Inc. (OTC PINK:MDCE) today highlighted the strength of its diversified business model following the successful launch and revamp of its corporate and subsidiary websites. By operating across complementary sectors - artificial intelligence imaging, digital wellness, enterprise Vision API services, and high-value collectibles authentication and auctions - the Company is well-positioned with multiple paths to success...

Read more

Envision Pharma Group Promotes Jennifer Lospinoso to President, Riparian

June 25, 2026 9:00 AM

Envision Pharma Group (Envision) has appointed Jennifer (Jenn) Lospinoso as President of Riparian, its business unit focused on pricing, access, and value optimization for pharmaceutical and biotech companies. "Jenn's promotion reflects her exceptional leadership, deep industry expertise, and unwavering commitment to clients," said Tom Langan, CEO of Envision. "Riparian represents a significant growth opportunity for Envision, and I'm...

Read more

DirectTrust(R) Announces Appointment of New and Returning Board Members, Commissioners

June 25, 2026 9:00 AM

DirectTrust®, a non-profit healthcare industry alliance focused on furthering trust in healthcare data exchange through standards, accreditation, and other services, today announced new and returning members of its Board of Directors and updates to its Electronic Healthcare Network Accreditation Commission (EHNAC).New Board members elected to serve three-year terms through June 2029 include:Dag Jakobsen, CEO, JakobsenID, Inc.Lenel James,...

Read more

Jaguar Health Announces Conversion of Series O Convertible Preferred Stock Issued as Recent One-time Stock Dividend

June 25, 2026 9:00 AM

Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or "the Company") hereby notifies holders of its Series O Convertible Preferred Stock, par value $0.0001 per share (CUSIP No. 47010C870) (the "Preferred Stock"), that the Company has exercised its right to cause the optional conversion of the Preferred Stock pursuant to Section 6(a) of the Certificate of Designation of Preferences, Rights and Limitations of Series O Convertible Preferred Stock. Each...

Read more

Navix Health Partners with APT Financial to Bring Native Payment Processing to Behavioral Health Facilities

June 25, 2026 9:00 AM

Navix Health, the AI-native CRM, EMR, and RCM platform built for behavioral health treatment facilities, today announced a partnership with APT Financial to deliver payment processing natively within the Navix platform. The integration lets facilities collect patient payments where they already manage clinical and billing workflows, rather than through a separate, disconnected system.With the integration live now, facilities using Navix can...

Read more

VSee Health Realizes 20X Expansion of its Hospital Network to 58 Locations

June 25, 2026 8:30 AM

VSee Health, Inc. (NASDAQ:VSEE) ("VSee" or the "Company"), a leading provider of telehealth and digital health solutions, is pleased to announce that its hospital footprint has grown to 58 locations, up from just 3 in approximately two tears. This dramatic ramp of 20-fold over the past two years, has led to a significant +80% growth in revenue in 2025 to $11.4 million.This growth in the VSee hospital network has been driven by expanding...

Read more

MIRA Pharmaceuticals Reports New Preclinical Data Demonstrating Mira-55's Differentiated Mechanism of Action and Anxiolytic Activity Relative to THC

June 25, 2026 8:15 AM

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) ("MIRA" or the "Company"), a clinical-stage pharmaceutical company developing novel therapies for neurologic, neuropsychiatric, and metabolic disorders, today announced new preclinical pharmacology data on Mira-55, the Company's cannabinoid analog in development for chronic inflammatory pain. Mira-55 is designed to act on the same cannabinoid receptors as compounds found in cannabis, including THC. A...

Read more

Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Arimidex(R)

June 25, 2026 8:00 AM

Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company specializing in generic and specialty prescription medications, is pleased to announce the approval of its generic Anastrozole tablets of 1mg for the Canadian market. Anastrozole is the generic equivalent of the brand name breast cancer drug, Arimidex®.Anastrozole is a highly prescribed non-steroidal aromatase inhibitor. It works by lowering estrogen levels...

Read more